Allogene Therapeutics
Latest round
- Series A
Last raised
- Apr 2018
Total raised
- $412M
Investors
- 7
About Allogene Therapeutics
Allogene Therapeutics, Inc.Allogene Therapeutics was founded in 2018 and is headquartered in South San Francisco, US. The company specializes in the development of AlloCAR T™ products.Allogene Therapeutics develops investigational AlloCAR T™ products, including ALLO-501, designed to treat relapsed/refractory non-Hodgkin lymphoma, and ALLO-329, aimed at autoimmune diseases such as lupus and scleroderma. The company’s therapies are engineered for immediate patient access, eliminating complex logistics associated with traditional methods.In the most recent year, Allogene Therapeutics reported revenue of USD 22,000.Allogene Therapeutics aims to expand its product pipeline focusing on AlloCAR T™ therapies targeting various cancer types and autoimmune disorders.
Who invested in Allogene Therapeutics
7 investors across 1 round
See all investors in Allogene Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 9, 2018
Amount
$412M
Investors
Questions about Allogene Therapeutics
Who invested in Allogene Therapeutics?
Allogene Therapeutics has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Allogene Therapeutics raised?
Allogene Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Allogene Therapeutics last raise money?
Allogene Therapeutics's most recent round on record is a Series A, in Apr 2018.
What does Allogene Therapeutics do?
Allogene Therapeutics is a biotechnology company.
Where is Allogene Therapeutics headquartered?
Allogene Therapeutics is headquartered in South San Francisco, US.
Which VCs invest in companies like Allogene Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Allogene Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Allogene Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.